Status:
UNKNOWN
Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
Phase:
NA
Brief Summary
Primary pulmonary hypertension (PPH) is a rare lung disorder in which the blood pressure in the pulmonary artery rises far above normal levels for no apparent reason. The pulmonary artery is a blood v...
Eligibility Criteria
Inclusion
- diagnosed as idiopathic pulmonary artery hypertension and associated family
Exclusion
- none
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00173537
Start Date
July 1 2005
End Date
December 1 2013
Last Update
December 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 10002